144 related articles for article (PubMed ID: 26170662)
21. Intracellular cleavable poly(2-dimethylaminoethyl methacrylate) functionalized mesoporous silica nanoparticles for efficient siRNA delivery in vitro and in vivo.
Lin D; Cheng Q; Jiang Q; Huang Y; Yang Z; Han S; Zhao Y; Guo S; Liang Z; Dong A
Nanoscale; 2013 May; 5(10):4291-301. PubMed ID: 23552843
[TBL] [Abstract][Full Text] [Related]
22. Formulation of glutathione responsive anti-proliferative nanoparticles from thiolated Akt1 siRNA and disulfide-crosslinked PEI for efficient anti-cancer gene therapy.
Muthiah M; Che HL; Kalash S; Jo J; Choi SY; Kim WJ; Cho CS; Lee JY; Park IK
Colloids Surf B Biointerfaces; 2015 Feb; 126():322-7. PubMed ID: 25576812
[TBL] [Abstract][Full Text] [Related]
23. Nanoparticle siRNA against BMI-1 with a Polyethylenimine-Laminarin Conjugate for Gene Therapy in Human Breast Cancer.
Ren X; Liu L; Zhou Y; Zhu Y; Zhang H; Zhang Z; Li H
Bioconjug Chem; 2016 Jan; 27(1):66-73. PubMed ID: 26629893
[TBL] [Abstract][Full Text] [Related]
24. siRNA Targeting of the SNCG Gene Inhibits the Growth of Gastric Carcinoma SGC7901 Cells in vitro and in vivo by Downregulating the Phosphorylation of AKT/ERK.
Fan C; Liu J; Tian J; Zhang Y; Yan M; Zhu C
Cytogenet Genome Res; 2018; 154(4):209-216. PubMed ID: 29902801
[TBL] [Abstract][Full Text] [Related]
25. Novel Survivin-Targeted Small Interfering RNA Delivered by Nanoparticles.
Feng C; Wang T; Zhang Y; Qu K; Tang S
Am J Med Sci; 2017 Nov; 354(5):506-512. PubMed ID: 29173363
[TBL] [Abstract][Full Text] [Related]
26. VEGF siRNA delivered by polycation liposome-encapsulated calcium phosphate nanoparticles for tumor angiogenesis inhibition in breast cancer.
Chen J; Sun X; Shao R; Xu Y; Gao J; Liang W
Int J Nanomedicine; 2017; 12():6075-6088. PubMed ID: 28860767
[TBL] [Abstract][Full Text] [Related]
27. Systemic delivery of siRNA specific to tumor mediated by atelocollagen: combined therapy using siRNA targeting Bcl-xL and cisplatin against prostate cancer.
Mu P; Nagahara S; Makita N; Tarumi Y; Kadomatsu K; Takei Y
Int J Cancer; 2009 Dec; 125(12):2978-90. PubMed ID: 19422046
[TBL] [Abstract][Full Text] [Related]
28. Post-Transcriptional Regulation of the GASC1 Oncogene with Active Tumor-Targeted siRNA-Nanoparticles.
Movassaghian S; Xie Y; Hildebrandt C; Rosati R; Li Y; Kim NH; Conti DS; da Rocha SR; Yang ZQ; Merkel OM
Mol Pharm; 2016 Aug; 13(8):2605-21. PubMed ID: 27223606
[TBL] [Abstract][Full Text] [Related]
29. Suppression of tumor growth in xenograft model mice by small interfering RNA targeting osteopontin delivery using biocompatible poly(amino ester).
Minai-Tehrani A; Jiang HL; Kim YK; Chung YS; Yu KN; Kim JE; Shin JY; Hong SH; Lee JH; Kim HJ; Chang SH; Park S; Kang BN; Cho CS; Cho MH
Int J Pharm; 2012 Jul; 431(1-2):197-203. PubMed ID: 22531848
[TBL] [Abstract][Full Text] [Related]
30. [Inhibitory effect of adenovirus-mediated short hairpin RNA targeting P85 and Akt1 on growth of human gastric adenocarcinoma cell].
Zhang J; Fu YC; Kang CS; Zhang QY; Wang T; Zhang J
Zhonghua Nei Ke Za Zhi; 2009 Jul; 48(7):557-61. PubMed ID: 19957795
[TBL] [Abstract][Full Text] [Related]
31. Luminescent/magnetic PLGA-based hybrid nanocomposites: a smart nanocarrier system for targeted codelivery and dual-modality imaging in cancer theranostics.
Shen X; Li T; Chen Z; Geng Y; Xie X; Li S; Yang H; Wu C; Liu Y
Int J Nanomedicine; 2017; 12():4299-4322. PubMed ID: 28652734
[TBL] [Abstract][Full Text] [Related]
32. [Small interference RNAs directed against KDR gene inhibit the proliferation of breast cancer cells in vitro and in vivo].
Zhang XJ; Ge YL; Hou L; Li Q
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Jan; 24(1):58-61. PubMed ID: 18177622
[TBL] [Abstract][Full Text] [Related]
33. Mitoxantrone-preloaded water-responsive phospholipid-amorphous calcium carbonate hybrid nanoparticles for targeted and effective cancer therapy.
Wang C; Han M; Liu X; Chen S; Hu F; Sun J; Yuan H
Int J Nanomedicine; 2019; 14():1503-1517. PubMed ID: 30880961
[TBL] [Abstract][Full Text] [Related]
34. Combination Therapy with AKT3 and PI3KCA siRNA Enhances the Antitumor Effect of Temozolomide and Carmustine in T98G Glioblastoma Multiforme Cells.
Paul-Samojedny M; Pudełko A; Kowalczyk M; Fila-Daniłow A; Suchanek-Raif R; Borkowska P; Kowalski J
BioDrugs; 2016 Apr; 30(2):129-44. PubMed ID: 26902608
[TBL] [Abstract][Full Text] [Related]
35. Anti-tumor effects in mice induced by survivin-targeted siRNA delivered through polysaccharide nanoparticles.
Yang F; Huang W; Li Y; Liu S; Jin M; Wang Y; Jia L; Gao Z
Biomaterials; 2013 Jul; 34(22):5689-99. PubMed ID: 23632321
[TBL] [Abstract][Full Text] [Related]
36. Silencing of the metastasis-linked gene, AEG-1, using siRNA-loaded cholamine surface-modified gelatin nanoparticles in the breast carcinoma cell line MCF-7.
Abozeid SM; Hathout RM; Abou-Aisha K
Colloids Surf B Biointerfaces; 2016 Sep; 145():607-616. PubMed ID: 27285732
[TBL] [Abstract][Full Text] [Related]
37. Poly(beta-amino ester) as a carrier for si/shRNA delivery in lung cancer cells.
Jere D; Xu CX; Arote R; Yun CH; Cho MH; Cho CS
Biomaterials; 2008 Jun; 29(16):2535-47. PubMed ID: 18316120
[TBL] [Abstract][Full Text] [Related]
38. Aptamer-protamine-siRNA nanoparticles in targeted therapy of ErbB3 positive breast cancer cells.
Xu X; Li L; Li X; Tao D; Zhang P; Gong J
Int J Pharm; 2020 Nov; 590():119963. PubMed ID: 33039492
[TBL] [Abstract][Full Text] [Related]
39. Direct cytosolic siRNA delivery by reconstituted high density lipoprotein for target-specific therapy of tumor angiogenesis.
Ding Y; Wang Y; Zhou J; Gu X; Wang W; Liu C; Bao X; Wang C; Li Y; Zhang Q
Biomaterials; 2014 Aug; 35(25):7214-27. PubMed ID: 24875759
[TBL] [Abstract][Full Text] [Related]
40. [Effect of siRNA transfection targeting VEGF gene on proliferation and apoptosis of human breast cancer cells].
Zhang X; Xu WH; Ge YL; Hou L; Li Q
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Jan; 23(1):14-7. PubMed ID: 17210097
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
